array(3) { ["company_details"]=> array(13) { ["name"]=> string(29) "Gcp Applied Technologies Inc." ["slug"]=> string(37) "07e15-us-gcp-applied-technologies-inc" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/49fe1b46-34d6-43fa-9b25-298bdc9cc2a4" ["description"]=> string(499) "GCP is a leading global provider of construction products that include high-performance specialty construction chemicals and building materials. GCP partners with producers, contractors, designers and engineers to achieve performance and sustainability goals. The company has a legacy of first to market and award-winning solutions that have been used to build some of the world’s most renowned structures. GCP is focused on continuous improvement for its customers, end-users and the environment." ["address_street"]=> string(18) "2325 Lakeview Pkwy" ["address_place"]=> string(10) "Alpharetta" ["address_region"]=> string(7) "Georgia" ["founding_date"]=> string(10) "2015-02-28" ["website_domain"]=> string(9) "gcpat.com" ["website_url"]=> string(17) "https://gcpat.com" ["industry_codes"]=> array(2) { [0]=> string(56) "Industrial Inorganic Chemicals, Not Elsewhere Classified" [1]=> string(61) "Chemicals and Chemical Preparations, Not Elsewhere Classified" } ["employee_count"]=> int(1800) ["article_count"]=> int(213) } ["articles"]=> array(3) { [0]=> array(7) { ["title_en"]=> string(62) "Clinical Microbiomics expanding with €10M million investment" ["snippet_en"]=> string(123) "Danish microbiome research company Clinical Microbiomics A/S has received €10 million in funding from Seventure Partners." ["url"]=> string(69) "https://www.labiotech.eu/trends-news/clinical-microbiomics-expanding/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/25f5d467-1a8e-4a27-ac03-f4c1c260ab78" ["source"]=> string(12) "labiotech.eu" ["publication_date"]=> string(10) "2022-10-11" ["categories"]=> array(4) { [0]=> string(16) "Customer Welfare" [1]=> string(18) "General Investment" [2]=> string(17) "Academic Research" [3]=> string(19) "Investment Requests" } } [1]=> array(7) { ["title_en"]=> string(60) "GCP Applied Technologies Inc. Adopts Stockholder Rights Plan" ["snippet_en"]=> string(257) "GCP Applied Technologies Inc. GCP, +1.77% (“GCP”) announced today that its Board of Directors has adopted a stockholder rights plan and declared a dividend distribution of one preferred share purchase right on each outstanding share of GCP common stock." ["url"]=> string(112) "https://www.marketwatch.com/press-release/gcp-applied-technologies-inc-adopts-stockholder-rights-plan-2019-03-15" ["image_url"]=> string(78) "https://images.businessradar.com/articles/cda8c04e-89d0-4c5c-9281-217940d61f15" ["source"]=> string(15) "marketwatch.com" ["publication_date"]=> string(10) "2019-03-15" ["categories"]=> array(4) { [0]=> string(31) "Financial Update/Profit Warning" [1]=> string(12) "Stock Market" [2]=> string(18) "General Investment" [3]=> string(36) "Human Rights and Community Relations" } } [2]=> array(7) { ["title_en"]=> string(127) "Stock Review for Specialty Chemicals Investors -- Axalta Coating Systems, Delta Technology, Ferro, and GCP Applied Technologies" ["snippet_en"]=> string(160) "NEW YORK, Feb. 22, 2018 /PRNewswire/ -- WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports..." ["url"]=> string(180) "https://www.prnewswire.com/news-releases/stock-review-for-specialty-chemicals-investors----axalta-coating-systems-delta-technology-ferro-and-gcp-applied-technologies-300602586.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/4e397d5a-97fa-496e-a739-2e7e3dd90fee" ["source"]=> string(14) "prnewswire.com" ["publication_date"]=> string(10) "2018-02-22" ["categories"]=> array(3) { [0]=> string(12) "Stock Market" [1]=> string(14) "Product Review" [2]=> string(18) "General Investment" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(17) } [1]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(13) } [2]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(12) } [3]=> array(2) { ["name"]=> string(18) "Activist Investors" ["count"]=> int(7) } [4]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(6) } [5]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(6) } [6]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(5) } [7]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(5) } [8]=> array(2) { ["name"]=> string(13) "GHG Emissions" ["count"]=> int(4) } [9]=> array(2) { ["name"]=> string(17) "Academic Research" ["count"]=> int(4) } [10]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(4) } [11]=> array(2) { ["name"]=> string(46) "Management of Legal and Regulatory Environment" ["count"]=> int(4) } [12]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(4) } [13]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(4) } [14]=> array(2) { ["name"]=> string(19) "Green & Responsible" ["count"]=> int(4) } [15]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(3) } [16]=> array(2) { ["name"]=> string(20) "Corporate Governance" ["count"]=> int(3) } [17]=> array(2) { ["name"]=> string(5) "Event" ["count"]=> int(3) } [18]=> array(2) { ["name"]=> string(25) "Leadership and Governance" ["count"]=> int(3) } [19]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(3) } [20]=> array(2) { ["name"]=> string(21) "Shareholders Feedback" ["count"]=> int(3) } [21]=> array(2) { ["name"]=> string(14) "Issuing Shares" ["count"]=> int(2) } [22]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(2) } [23]=> array(2) { ["name"]=> string(11) "Sponsorship" ["count"]=> int(2) } [24]=> array(2) { ["name"]=> string(24) "Access and affordability" ["count"]=> int(2) } [25]=> array(2) { ["name"]=> string(20) "Business Development" ["count"]=> int(2) } [26]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(2) } [27]=> array(2) { ["name"]=> string(17) "Energy Management" ["count"]=> int(2) } [28]=> array(2) { ["name"]=> string(33) "Materials Sourcing and Efficiency" ["count"]=> int(2) } [29]=> array(2) { ["name"]=> string(19) "Under Investigation" ["count"]=> int(2) } } } 07e15-us-gcp-applied-technologies-inc

Gcp Applied Technologies Inc.

Location

Georgia

Founded

2015-02-28

Website

https://gcpat.com

Articles

213 Articles

Category

Industrial Inorganic Chemicals, Not Elsewhere Classified

Chemicals and Chemical Preparations, Not Elsewhere Classified

Description

GCP is a leading global provider of construction products that include high-performance specialty construction chemicals and building materials. GCP partners with producers, contractors, designers and engineers to achieve performance and sustainability goals. The company has a legacy of first to market and award-winning solutions that have been used to build some of the world’s most renowned structures. GCP is focused on continuous improvement for its customers, end-users and the environment.

Articles

Clinical Microbiomics expanding with €10M million investment

2022-10-11 (labiotech.eu)

Clinical Microbiomics expanding with €10M million investment

Danish microbiome research company Clinical Microbiomics A/S has received €10 million in funding from Seventure Partners.

Read more
GCP Applied Technologies Inc. Adopts Stockholder Rights Plan

2019-03-15 (marketwatch.com)

GCP Applied Technologies Inc. Adopts Stockholder Rights Plan

GCP Applied Technologies Inc. GCP, +1.77% (“GCP”) announced today that its Board of Directors has adopted a stockholder rights plan and declared a dividend distribution of one preferred share purchase right on each outstanding share of GCP common stock.

Read more
Stock Review for Specialty Chemicals Investors -- Axalta Coating Systems, Delta Technology, Ferro, and GCP Applied Technologies

2018-02-22 (prnewswire.com)

Stock Review for Specialty Chemicals Investors -- Axalta Coating Systems, Delta Technology, Ferro, and GCP Applied Technologies

NEW YORK, Feb. 22, 2018 /PRNewswire/ -- WallStEquities.com strives to bring the best free research to the investment community. Today we are offering reports...

Read more

Newsletter subscription